FLT3 and acute myeloid leukemia: Mutations in plasma membrane-bound FLT3-ITD, a major genetic lesion leading to AML development, have been demonstrated to cause altered signal transduction, phosphorylation of STAT5, and consequent activation of RAC1, increasing ROS production.